Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

1.

[Neuron-specific enolase (NSE) serum level as a prognostic factor in non-small cell lung cancer].

Zych J, Szturmowicz M, Sakowicz A, Słodkowska J, Załeska M, Radzikowska E, Załeska J, Jodkiewicz Z, Rowińska-Zakrzewska E.

Pneumonol Alergol Pol. 2002;70(5-6):278-83. Polish.

PMID:
12518626
[PubMed - indexed for MEDLINE]
2.

Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.

van Zandwijk N, Jassem E, Bonfrer JM, Mooi WJ, van Tinteren H.

Semin Oncol. 1992 Feb;19(1 Suppl 2):37-43.

PMID:
1329221
[PubMed - indexed for MEDLINE]
3.

[Elevated serum NSE level in locally advanced and metastatic NSCLC predispose to better response to chemotherapy but worse survival].

Załeska M, Szturmowicz M, Zych J, Roszkowska-Sliz B, Demkow U, Langfort R, Roszkowski-Sliz K.

Pneumonol Alergol Pol. 2010;78(1):14-20. Polish.

PMID:
20162514
[PubMed - indexed for MEDLINE]
Free Article
4.

Prognostic factors in advanced non-small cell lung cancer: elevated serum levels of neuron specific enolase indicate poor prognosis.

Maeda T, Ueoka H, Tabata M, Kiura K, Shibayama T, Gemba K, Takigawa N, Hiraki A, Katayama H, Harada M.

Jpn J Clin Oncol. 2000 Dec;30(12):534-41.

PMID:
11210162
[PubMed - indexed for MEDLINE]
Free Article
5.

Neuron-specific enolase (NSE) serum level in non small cell lung cancer--can it be an indicator of tumour chemosensitivity?

Zych J, Sakowicz A, Radzikowska E, Załeska J, Rowińska-Zakrzewska E.

Rocz Akad Med Bialymst. 1997;42 Suppl 1:173-8.

PMID:
9337535
[PubMed - indexed for MEDLINE]
6.

[Pre-treatment and treatment-induced neuron-specific enolase in patients with small-cell lung cancer: an open prospective study].

Emin Erbaycu A, Gunduz A, Batum O, Zeren Ucar Z, Tuksavul F, Zeki Guclu S.

Arch Bronconeumol. 2010 Jul;46(7):364-9. doi: 10.1016/j.arbres.2010.04.005. Epub 2010 May 27. Spanish.

PMID:
20537457
[PubMed - indexed for MEDLINE]
Free Article
7.

The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer.

Nisman B, Heching N, Biran H, Barak V, Peretz T.

Tumour Biol. 2006;27(1):8-16. Epub 2005 Dec 8.

PMID:
16340245
[PubMed - indexed for MEDLINE]
8.

Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinoma.

Fizazi K, Cojean I, Pignon JP, Rixe O, Gatineau M, Hadef S, Arriagada R, Baldeyrou P, Comoy E, Le Chevalier T.

Cancer. 1998 Mar 15;82(6):1049-55.

PMID:
9506348
[PubMed - indexed for MEDLINE]
9.

Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer.

Bonner JA, Sloan JA, Rowland KM Jr, Klee GG, Kugler JW, Mailliard JA, Wiesenfeld M, Krook JE, Maksymiuk AW, Shaw EG, Marks RS, Perez EA.

Clin Cancer Res. 2000 Feb;6(2):597-601.

PMID:
10690544
[PubMed - indexed for MEDLINE]
Free Article
10.

Are levels of pro-gastrin-releasing peptide or neuron-specific enolase at relapse prognostic factors after relapse in patients with small-cell lung cancer?

Hirose T, Okuda K, Yamaoka T, Ishida K, Kusumoto S, Sugiyama T, Shirai T, Ohnshi T, Ohmori T, Adachi M.

Lung Cancer. 2011 Feb;71(2):224-8. doi: 10.1016/j.lungcan.2010.05.004.

PMID:
20537424
[PubMed - indexed for MEDLINE]
11.

Serum neuron specific enolase level as a prognostic factor in non-small cell lung cancer.

Andoh M, Gemma A, Takenaka K, Hisakatsu S, Yamada K, Usuki J, Hasegawa K, Sakonji M, Kudoh S, Tsuboi E, et al.

Intern Med. 1994 May;33(5):271-6.

PMID:
7949629
[PubMed - indexed for MEDLINE]
Free Article
12.

[Comparison of the degree of regression of small cell lung neoplasm in clinical-radiologic evaluation with levels of neuron specific enolase (NSE) in serum].

Rowińska-Zakrzewska E, Szturmowicz M, Sakowicz A, Pawlicka L, Remiszewki P, Szopiński J, Wiatr E, Zych J.

Pneumonol Alergol Pol. 1995;63(11-12):601-8. Polish.

PMID:
8616474
[PubMed - indexed for MEDLINE]
13.

Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer.

Carles J, Rosell R, Ariza A, Pellicer I, Sanchez JJ, Fernandez-Vasalo G, Abad A, Barnadas A.

Lung Cancer. 1993 Dec;10(3-4):209-19.

PMID:
7521264
[PubMed - indexed for MEDLINE]
14.

Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer.

Pujol JL, Quantin X, Jacot W, Boher JM, Grenier J, Lamy PJ.

Lung Cancer. 2003 Feb;39(2):131-8.

PMID:
12581564
[PubMed - indexed for MEDLINE]
15.

Serum neuron-specific enolase as a tumor marker in the diagnosis and follow-up of small-cell lung cancer.

Pinson P, Joos G, Watripont P, Brusselle G, Pauwels R.

Respiration. 1997;64(1):102-7.

PMID:
9044484
[PubMed - indexed for MEDLINE]
16.

Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients.

Pujol JL, Boher JM, Grenier J, Quantin X.

Lung Cancer. 2001 Feb-Mar;31(2-3):221-31.

PMID:
11165401
[PubMed - indexed for MEDLINE]
17.

Predictive and prognostic significance of neuron-specific enolase (NSE) in non-small cell lung cancer.

Tiseo M, Ardizzoni A, Cafferata MA, Loprevite M, Chiaramondia M, Filiberti R, Marroni P, Grossi F, Paganuzzi M.

Anticancer Res. 2008 Jan-Feb;28(1B):507-13.

PMID:
18383893
[PubMed - indexed for MEDLINE]
Free Article
18.

Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer.

Johnson PW, Joel SP, Love S, Butcher M, Pandian MR, Squires L, Wrigley PF, Slevin ML.

Br J Cancer. 1993 Apr;67(4):760-6.

PMID:
8385978
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

ProGRP and NSE in therapy monitoring in patients with small cell lung cancer.

Wójcik E, Kulpa JK, Sas-Korczyńska B, Korzeniowski S, Jakubowicz J.

Anticancer Res. 2008 Sep-Oct;28(5B):3027-33.

PMID:
19031951
[PubMed - indexed for MEDLINE]
Free Article
20.

Predictive factors of tumor response and prognostic factors of survival during lung cancer chemotherapy.

Ray P, Quantin X, Grenìer J, Pujol JL.

Cancer Detect Prev. 1998;22(4):293-304.

PMID:
9674872
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk